NHS Framework Agreement for the Supply of Human Normal Immunoglobulin & Anti-D Immunoglobulin
Awarded by NHS ENGLAND · 2023-02-03T15:49:39Z · £526,598,540
Description
Human Normal Immunoglobulin & Anti-D Immunoglobulin The purpose of this 'future opportunity' notice is to indicate that a live 'opportunity' may be published at a future date. However, any existing 'live' framework agreement may be subject to an extension up to the maximum extension period allowed.
- Buyer
- NHS ENGLAND
- Value
- £526,598,540
- Category (CPV)
- Immunoglobulins
- Award date
- 2023-02-03T15:49:39Z
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.